Concepedia

Nadia Zeghari-Squalli

NZ

Statistics

Publications

2

Citations

142

H-Index

2

Active since

1999

Affiliations

Hôpital Paul-Brousse(Current)

Nadia Zeghari-Squalli is an author at Hôpital Paul-Brousse specializing in medicine, malignant neoplasms, and dna topoisomerase i inhibition.

Publications per year

1999–1999

2

Publications

2

Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin.

Nadia Zeghari-Squalli, Éric Raymond, Esteban Cvitkovic et al. · PubMed · 1999 · 115 citations

, , +16

Cellular pharmacology of the combination of oxaliplatin with topotecan in the IGROV-1 human ovarian cancer cell line

François Goldwasser, Laurence Bozec, Nadia Zeghari-Squalli et al. · Anti-Cancer Drugs · 1999 · 27 citations

, , +17

1–2 of 2